CPR handles PR for worldwide antibiotic study

AstraZeneca Pharmaceuticals has appointed healthcare specialist CPR Worldwide to develop a PR programme in support of a worldwide surveillance study, which will monitor rates of antibiotic resistance around the world.

AstraZeneca Pharmaceuticals has appointed healthcare specialist CPR

Worldwide to develop a PR programme in support of a worldwide

surveillance study, which will monitor rates of antibiotic resistance

around the world.



The appointment, which follows a competitive three-way pitch, will see

the agency’s London office support the global activities of the

company’s in-house PR department.



The agency has also been awarded several product briefs relating to the

company’s pain, anaesthesia and infection therapy product areas.



Scott Clark, joint CEO of the agency, said that it was always a

challenge to get media attention for drugs that work in the area of pain

management and anesthesia because of media fatigue.



’On the face of it, it may not seem the most media friendly story, even

though these problems can affect large numbers of people either directly

or indirectly,’ he said.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.